href=”https://www.genengnews.com/topics/omics/mrna-day-trilink-maravai-look-to-rna-oligonucleotides-and-san-diego-for-growth/”>
A San Diego manufacturer of highly-modified nucleic acids and its parent company have concluded that development of RNA- and oligonucleotide-based therapeutics?as well as the region?s biopharma cluster?will both grow strongly enough in the near future to justify the companies? recent $50-million investment in relocation and expansion within the city.
